Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    May 2017
  1. SCHREVEL M, Osse EM, Prins FA, Trimbos JBMZ, et al
    Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3980.
    PubMed     Text format     Abstract available


  2. LIU Y, Murray-Stewart T, Casero RA Jr, Kagiampakis I, et al
    Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
    Int J Oncol. 2017 May 2. doi: 10.3892/ijo.2017.3979.
    PubMed     Text format     Abstract available


  3. PALMA FLORES C, Garcia-Vazquez R, Gallardo Rincon D, Ruiz-Garcia E, et al
    MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
    Int J Oncol. 2017;50:1461-1476.
    PubMed     Text format     Abstract available


  4. YANG J, Wang Y, Zeng Z, Qiao L, et al
    Smad4 deletion in blood vessel endothelial cells promotes ovarian cancer metastasis.
    Int J Oncol. 2017;50:1693-1700.
    PubMed     Text format     Abstract available


    April 2017
  5. XU J, Jiang N, Shi H, Zhao S, et al
    [Corrigendum] miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
    Int J Oncol. 2017 Apr 27. doi: 10.3892/ijo.2017.3977.
    PubMed     Text format     Abstract available


  6. PIAO J, You K, Guo Y, Zhang Y, et al
    Substrate stiffness affects epithelial-mesenchymal transition of cervical cancer cells through miR-106b and its target protein DAB2.
    Int J Oncol. 2017 Apr 27. doi: 10.3892/ijo.2017.3978.
    PubMed     Text format     Abstract available


  7. YANOKURA M, Banno K, Adachi M, Aoki D, et al
    Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3966.
    PubMed     Text format     Abstract available


    March 2017
  8. DEVOR EJ, Gonzalez-Bosquet J, Warrier A, Reyes HD, et al
    p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers.
    Int J Oncol. 2017 Mar 23. doi: 10.3892/ijo.2017.3931.
    PubMed     Text format     Abstract available


  9. CHANG YS, Huang HD, Yeh KT, Chang JG, et al
    Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
    Int J Oncol. 2017 Mar 20. doi: 10.3892/ijo.2017.3919.
    PubMed     Text format     Abstract available


  10. XU J, Jiang N, Shi H, Zhao S, et al
    miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.
    Int J Oncol. 2017 Mar 16. doi: 10.3892/ijo.2017.3915.
    PubMed     Text format     Abstract available


  11. YOKOYAMA T, Kohn EC, Brill E, Lee JM, et al
    Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP.
    Int J Oncol. 2017 Mar 15. doi: 10.3892/ijo.2017.3914.
    PubMed     Text format     Abstract available


  12. CHA HJ, Choi JH, Park IC, Kim CH, et al
    Selective FGFR inhibitor BGJ398 inhibits phosphorylation of AKT and STAT3 and induces cytotoxicity in sphere-cultured ovarian cancer cells.
    Int J Oncol. 2017 Mar 15. doi: 10.3892/ijo.2017.3913.
    PubMed     Text format     Abstract available


  13. LI J, Li Q, Huang H, Li Y, et al
    Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3898.
    PubMed     Text format     Abstract available


  14. SU K, Wang CF, Zhang Y, Cai YJ, et al
    miR-940 upregulation contributes to human cervical cancer progression through p27 and PTEN inhibition.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3897.
    PubMed     Text format     Abstract available


  15. WANG Y, Compton C, Rankin GO, Cutler SJ, et al
    3-Hydroxyterphenyllin, a natural fungal metabolite, induces apoptosis and S phase arrest in human ovarian carcinoma cells.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3894.
    PubMed     Text format     Abstract available


    February 2017
  16. VERA CA, Orostica L, Gabler F, Ferreira A, et al
    The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Int J Oncol. 2017 Feb 28. doi: 10.3892/ijo.2017.3892.
    PubMed     Text format     Abstract available


  17. SATO M, Kawana K, Adachi K, Fujimoto A, et al
    Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
    Int J Oncol. 2017 Feb 23. doi: 10.3892/ijo.2017.3891.
    PubMed     Text format     Abstract available


  18. WANG S, Meng X, Dong Y
    Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction.
    Int J Oncol. 2017 Feb 22. doi: 10.3892/ijo.2017.3890.
    PubMed     Text format     Abstract available


  19. PARK SH, Chung YJ, Song JY, Kim SI, et al
    Mullerian inhibiting substance inhibits an ovarian cancer cell line via beta-catenin interacting protein deregulation of the Wnt signal pathway.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3874.
    PubMed     Text format     Abstract available


  20. ZHU X, Ji M, Han Y, Guo Y, et al
    PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.
    Int J Oncol. 2017 Feb 10. doi: 10.3892/ijo.2017.3873.
    PubMed     Text format     Abstract available


    January 2017
  21. ZHOU X, Yue Y, Wang R, Gong B, et al
    MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells.
    Int J Oncol. 2017 Jan 19. doi: 10.3892/ijo.2017.3857.
    PubMed     Text format     Abstract available


  22. ZHOU G, Peng F, Zhong Y, Chen Y, et al
    Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
    Int J Oncol. 2017 Jan 17. doi: 10.3892/ijo.2017.3853.
    PubMed     Text format     Abstract available


  23. CHEN C, Wang Y, Wang S, Liu Y, et al
    LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Int J Oncol. 2017 Jan 16. doi: 10.3892/ijo.2017.3849.
    PubMed     Text format     Abstract available


  24. WINSHIP A, Van Sinderen M, Heffernan-Marks A, Dimitriadis E, et al
    Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
    Int J Oncol. 2017 Jan 13. doi: 10.3892/ijo.2017.3848.
    PubMed     Text format     Abstract available


    December 2016
  25. OTTE A, Yang Y, von der Ohe J, Melzer C, et al
    SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.
    Int J Oncol. 2016;49:2453-2463.
    PubMed     Text format     Abstract available


    November 2016
  26. ZHANG W, He W, Shi Y, Zhao J, et al
    Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Int J Oncol. 2016 Nov 29. doi: 10.3892/ijo.2016.3784.
    PubMed     Text format     Abstract available


  27. FU QR, Song W, Deng YT, Li HL, et al
    ESC-3 induces apoptosis of human ovarian carcinomas through Wnt/beta-catenin and Notch signaling in vitro and in vivo.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3773.
    PubMed     Text format     Abstract available


  28. TURCONI G, Scaldaferri D, Fabbri M, Monti L, et al
    RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model.
    Int J Oncol. 2016 Nov 9. doi: 10.3892/ijo.2016.3763.
    PubMed     Text format     Abstract available


    October 2016
  29. NARAYANAN R, Kim HN, Narayanan NK, Nargi D, et al
    [Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.
    Int J Oncol. 2016 Oct 18. doi: 10.3892/ijo.2016.3737.
    PubMed     Text format     Abstract available


  30. XIE Q, Su J, Jiao B, Shen L, et al
    ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Int J Oncol. 2016 Oct 13. doi: 10.3892/ijo.2016.3733.
    PubMed     Text format     Abstract available


  31. INOUE T, Adachi K, Kawana K, Taguchi A, et al
    Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor.
    Int J Oncol. 2016;49:1297-304.
    PubMed     Text format     Abstract available


    September 2016
  32. CHEN WC, Hsu HP, Li CY, Yang YJ, et al
    Cancer stem cell marker CD90 inhibits ovarian cancer formation via beta3 integrin.
    Int J Oncol. 2016 Sep 15. doi: 10.3892/ijo.2016.3691.
    PubMed     Text format     Abstract available


  33. LEE J, An S, Choi YM, Lee J, et al
    Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3683.
    PubMed     Text format     Abstract available


  34. NAKAMURA H, Taguchi A, Kawana K, Kawata A, et al
    STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3681.
    PubMed     Text format     Abstract available


  35. PUVANENTHIRAN S, Essapen S, Seddon AM, Modjtahedi H, et al
    Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3678.
    PubMed     Text format     Abstract available


  36. SUN J, Chu H, Ji J, Huo G, et al
    Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer.
    Int J Oncol. 2016;49:943-52.
    PubMed     Text format     Abstract available


  37. MASUYAMA H, Nakamura K, Nobumoto E, Hiramatsu Y, et al
    Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
    Int J Oncol. 2016;49:1211-20.
    PubMed     Text format     Abstract available


    August 2016
  38. TAN ZW, Xie S, Hu SY, Liao T, et al
    Caudatin targets TNFAIP1/NF-kappaB and cytochrome c/caspase signaling to suppress tumor progression in human uterine cancer.
    Int J Oncol. 2016 Aug 19. doi: 10.3892/ijo.2016.3662.
    PubMed     Text format     Abstract available


  39. PENG Z, Wang Q, Zhang Y, He J, et al
    EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3655.
    PubMed     Text format     Abstract available


  40. WU W, Wang Q, Yin F, Yang Z, et al
    Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.
    Int J Oncol. 2016 Aug 10. doi: 10.3892/ijo.2016.3652.
    PubMed     Text format     Abstract available


  41. GOMEZ-GOMEZ Y, Organista-Nava J, Ocadiz-Delgado R, Garcia-Villa E, et al
    The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17beta-estradiol.
    Int J Oncol. 2016;49:549-58.
    PubMed     Text format     Abstract available


    July 2016
  42. LOPEZ-URRUTIA E, Pedroza-Torres A, Fernandez-Retana J, De Leon DC, et al
    PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements.
    Int J Oncol. 2016;49:371-80.
    PubMed     Text format     Abstract available


    June 2016
  43. CHEN C, Chang YC, Lan MS, Breslin M, et al
    [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Int J Oncol. 2016 Jun 6. doi: 10.3892/ijo.2016.3564.
    PubMed     Text format     Abstract available


  44. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    PubMed     Text format     Abstract available


  45. XIANG XY, Kang JS, Yang XC, Su J, et al
    SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3552.
    PubMed     Text format     Abstract available


  46. WANG D, Saga Y, Sato N, Nakamura T, et al
    The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway.
    Int J Oncol. 2016;48:2303-9.
    PubMed     Text format     Abstract available


  47. SUN L, Xia WY, Zhao SH, Liu N, et al
    An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
    Int J Oncol. 2016;48:2461-71.
    PubMed     Text format     Abstract available


    May 2016
  48. ROGERS-BROADWAY KR, Chudasama D, Pados G, Tsolakidis D, et al
    Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro.
    Int J Oncol. 2016 May 18. doi: 10.3892/ijo.2016.3531.
    PubMed     Text format     Abstract available


  49. QI X, Du L, Chen X, Chen L, et al
    VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3527.
    PubMed     Text format     Abstract available


  50. FENG S, Yang Y, Lv J, Sun L, et al
    Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation.
    Int J Oncol. 2016 May 6. doi: 10.3892/ijo.2016.3508.
    PubMed     Text format     Abstract available


    March 2016
  51. AGUILAR-ROJAS A, Perez-Solis MA, Maya-Nunez G
    The gonadotropin-releasing hormone system: Perspectives from reproduction to cancer (Review).
    Int J Oncol. 2016;48:861-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: